Skip to main content
Premium Trial:

Request an Annual Quote

OmniViz Set for Aug. 31 Launch of Data-Mining Software Built With J&J

NEW YORK, Aug. 27 - OmniViz said it will release on Saturday new bioinformatics software co-developed by Johnson & Johnson's  pharmaceutical R&D arm.

 

The software allows researchers to mine data from various sources, including text and patent searches, clinical information, and genomic and proteomic data, according to Jeff Saffer, chief technology officer and acting president of OmniViz.

 

The technology was designed through an ongoing relationship with J&J, through which the pharma company gets early access to software updates and input in software design, said Saffer.

 

Though he declined to disclose what J&J pays for the early access, Saffer described the collaboration as a "long-term relationship."

 

Michael Jackson, vice president for drug discovery at R W Johnson Pharmaceutical Research Institute, said his bioinformatics staff is working closely with OmniViz. The software, he said, "mixes different data sources together. I believe this is where you have to go."

 

Maynard, Mass.-based OmniViz has a similar relationship with BASF Plant Sciences, said Saffer.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.